NM_000162.5(GCK):c.626C>T (p.Thr209Met) AND Maturity onset diabetes mellitus in young

Germline classification:: Likely pathogenic/Likely risk allele (2 submissions)
Last evaluated:: Jul 26, 2017
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002354899.3

Allele description [Variation Report for NM_000162.5(GCK):c.626C>T (p.Thr209Met)]

NM_000162.5(GCK):c.626C>T (p.Thr209Met)

Gene:

GCK:glucokinase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p13

Genomic location:

Preferred name:

NM_000162.5(GCK):c.626C>T (p.Thr209Met)

HGVS:

NC_000007.14:g.44149813G>A
NG_008847.2:g.53358C>T
NM_000162.5:c.626C>TMANE SELECT
NM_001354800.1:c.626C>T
NM_033507.3:c.629C>T
NM_033508.3:c.623C>T
NP_000153.1:p.Thr209Met
NP_001341729.1:p.Thr209Met
NP_277042.1:p.Thr210Met
NP_277043.1:p.Thr208Met
LRG_1074t1:c.626C>T
LRG_1074t2:c.629C>T
LRG_1074:g.53358C>T
LRG_1074p1:p.Thr209Met
LRG_1074p2:p.Thr210Met
NC_000007.13:g.44189412G>A
NC_000007.13:g.44189412G>A
NM_000162.3:c.626C>T

Protein change:

T208M

Links:

dbSNP: rs1583599303

NCBI 1000 Genomes Browser:

rs1583599303

Molecular consequence:

NM_000162.5:c.626C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001354800.1:c.626C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_033507.3:c.629C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_033508.3:c.623C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Maturity onset diabetes mellitus in young (MODY)
Synonyms:: Mason type diabetes
Identifiers:: MONDO: MONDO:0018911; MedGen: C0342276; Orphanet: 552; OMIM: 606391; Human Phenotype Ontology: HP:0004904

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002605193	Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic	criteria provided, single submitter (K & H Uppaluri Personalized Medicine Clinic Variant Classification & Assertion Criteria_Updated V.1)	Likely risk allele	unknown	research	PubMed (6) [See all records that cite these PMIDs] 33129248, 27269892, 32375122, 31197960, 30257192, 29510678 Citation Link,
SCV002655881	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Likely pathogenic (Jul 26, 2017)	germline	clinical testing	PubMed (5) [See all records that cite these PMIDs] 17573900, 19790256, 25306193, 25555642, 8168652 Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002605193

Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic

criteria provided, single submitter

(K & H Uppaluri Personalized Medicine Clinic Variant Classification & Assertion Criteria_Updated V.1)

Likely risk allele

unknown

research

PubMed (6)
[See all records that cite these PMIDs]

Citation Link,

SCV002655881

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Likely pathogenic
(Jul 26, 2017)

germline

clinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	research

Citations

PubMed

Clinical implications of the glucokinase impaired function - GCK MODY today.

Hulín J, Škopková M, Valkovičová T, Mikulajová S, Rosoľanková M, Papcun P, Gašperíková D, Staník J.

Physiol Res. 2020 Dec 22;69(6):995-1011. Epub 2020 Nov 2. Review.

PubMed [citation]

PMID:: 33129248
PMCID:: PMC8549873

GCK mutations in Chinese MODY2 patients: a family pedigree report and review of Chinese literature.

Ping Xiao Y, Hua Xu X, Lan Fang Y, Jiang L, Chen C, Liang L, Lin Wang C.

J Pediatr Endocrinol Metab. 2016 Aug 1;29(8):959-64. doi: 10.1515/jpem-2015-0354. Review.

PubMed [citation]

PMID:: 27269892

See all PubMed Citations (11)

Details of each submission

From Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic, SCV002605193.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1		not provided	not provided	not provided	research	PubMed (6)

Description

Potent mutations in GCK gene is associated with poor secretion of insulin. Its associated with milder forms of diabetes, which can be controlled by diet . However, there is no sufficient evidence to ascertain the significance of rs1583599303 in MODY, yet.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Ambry Genetics, SCV002655881.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (5)

Description

The p.T209M variant (also known as c.626C>T), located in coding exon 6 of the GCK gene, results from a C to T substitution at nucleotide position 626. The threonine at codon 209 is replaced by methionine, an amino acid with similar properties. This variant was identified in multiple maturity-onset diabetes of the young families (Osbak KK et al. Hum. Mutat., 2009 Nov;30:1512-26; Alkorta-Aranburu G et al. Mol. Genet. Metab., 2014 Dec;113:315-20). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine